121 related articles for article (PubMed ID: 16095140)
1. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report.
Ciprandi G; Fenoglio D; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Puppo F
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):38-44. PubMed ID: 16095140
[TBL] [Abstract][Full Text] [Related]
2. Sublingual specific immunotherapy reduces PBMC proliferations.
Fenoglio D; Puppo F; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Marseglia G; Ciprandi G
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):147-51. PubMed ID: 15916016
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports.
Ciprandi G; Cirillo I; Fenoglio D; Marseglia G; Tosca MA
Int Immunopharmacol; 2006 Aug; 6(8):1370-3. PubMed ID: 16782551
[TBL] [Abstract][Full Text] [Related]
4. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
7. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
9. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.
Kim ST; Han DH; Moon IJ; Lee CH; Min YG; Rhee CS
Am J Rhinol Allergy; 2010; 24(4):271-5. PubMed ID: 20819465
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT.
Wei W; Liu Y; Wang Y; Zhao Y; He J; Li X; Shen K
Int Arch Allergy Immunol; 2010; 153(1):19-26. PubMed ID: 20357481
[TBL] [Abstract][Full Text] [Related]
12. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
14. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
15. House dust mite-specific T cells in healthy non-atopic children.
Bullens DM; De Swerdt A; Dilissen E; Kasran A; Kroczek RA; Cadot P; Casaer P; Ceuppens JL
Clin Exp Allergy; 2005 Dec; 35(12):1535-41. PubMed ID: 16393318
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
17. Dermatophagoides-induced interleukin-10 production by peripheral blood lymphocytes from patients with asthma in remission.
Noma T; Sugawara Y; Ogawa N; Saeki T; Yamaguchi K; Kawano Y
Pediatr Allergy Immunol; 2004 Oct; 15(5):459-68. PubMed ID: 15482523
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]